Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The relationship between Lp(a) and CVD outcomes: a systematic review.
Forbes CA, Quek RG, Deshpande S, Worthy G, Wolff R, Stirk L, Kleijnen J, Gandra SR, Djedjos S, Wong ND. Forbes CA, et al. Among authors: worthy g. Lipids Health Dis. 2016 May 17;15:95. doi: 10.1186/s12944-016-0258-8. Lipids Health Dis. 2016. PMID: 27184891 Free PMC article. Review.
Relationship between changes in coronary atherosclerotic plaque burden measured by intravascular ultrasound and cardiovascular disease outcomes: a systematic literature review.
Forbes C, Quek RG, Deshpande S, Worthy G, Ross J, Kleijnen J, Gandra SR, Kassahun H, Wong ND, Nicholls SJ. Forbes C, et al. Among authors: worthy g. Curr Med Res Opin. 2016 Jun;32(6):1143-50. doi: 10.1185/03007995.2016.1162775. Epub 2016 Mar 17. Curr Med Res Opin. 2016. PMID: 26949994 Review.
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
Büyükkaramikli NC, de Groot S, Fayter D, Wolff R, Armstrong N, Stirk L, Worthy G, Albuquerque de Almeida F, Kleijnen J, Al MJ. Büyükkaramikli NC, et al. Among authors: worthy g. Pharmacoeconomics. 2018 Feb;36(2):145-159. doi: 10.1007/s40273-017-0581-6. Pharmacoeconomics. 2018. PMID: 29086363 Free PMC article. Review.
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pouwels XGLV, Wolff R, Ramaekers BLT, Van Giessen A, Lang S, Ryder S, Worthy G, Duffy S, Armstrong N, Kleijnen J, Joore MA. Pouwels XGLV, et al. Among authors: worthy g. Pharmacoeconomics. 2018 May;36(5):533-543. doi: 10.1007/s40273-017-0607-0. Pharmacoeconomics. 2018. PMID: 29344794 Free PMC article. Review.
Systematic review of tapentadol in chronic severe pain.
Riemsma R, Forbes C, Harker J, Worthy G, Misso K, Schäfer M, Kleijnen J, Stürzebecher S. Riemsma R, et al. Among authors: worthy g. Curr Med Res Opin. 2011 Oct;27(10):1907-30. doi: 10.1185/03007995.2011.611494. Epub 2011 Sep 12. Curr Med Res Opin. 2011. PMID: 21905968 Review.
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J. Riemsma R, et al. Among authors: worthy g. Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Health Technol Assess. 2016. PMID: 26933827 Free PMC article. Review.
Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, van Asselt ADI, Wolff R, Armstrong N, Worthy G, Chalker A, Buksnys T, Stirk L, Kleijnen J, Joore MA, Grimm SE. Witlox WJA, et al. Among authors: worthy g. Pharmacoeconomics. 2020 Apr;38(4):317-324. doi: 10.1007/s40273-019-00870-w. Pharmacoeconomics. 2020. PMID: 31814080 Free PMC article. Review.
Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ramaekers BLT, Wolff R, van Giessen A, Pouwels X, Fayter D, Lang S, Armstrong N, Worthy G, Duffy S, Kleijnen J, Joore MA. Ramaekers BLT, et al. Among authors: worthy g. Pharmacoeconomics. 2018 Mar;36(3):285-288. doi: 10.1007/s40273-017-0591-4. Pharmacoeconomics. 2018. PMID: 29177842 Free PMC article. Review.
75 results